Back to News
Market Impact: 0.32

Truist raises OneSpaWorld stock price target on wellness trends By Investing.com

Analyst EstimatesAnalyst InsightsCorporate EarningsCompany FundamentalsCorporate Guidance & OutlookTravel & Leisure
Truist raises OneSpaWorld stock price target on wellness trends By Investing.com

Truist raised OneSpaWorld's price target to $28 from $25 and kept a Buy rating, citing Medi-Spa growth, a higher Caribbean mix, and steady wellness spending. It also lifted 2026 Adjusted EBITDA to $137.9 million from $132.4 million and 2027 EBITDA to $154.3 million from $143.2 million, though EPS estimates were trimmed. Q1 2026 revenue rose 13% to $247.6 million and EPS came in at $0.27 versus $0.26 expected, supporting the positive view despite stated macro and geopolitical risks.

Analysis

The signal here is less about one stock and more about the durability of premium discretionary spend inside the cruise ecosystem. If affluent travelers are still buying wellness add-ons while broader mass-market travel softens, OSW effectively becomes a high-margin lever on onboard monetization rather than a simple passenger-volume story; that supports multiple expansion even if top-line growth moderates. The revised valuation implies the market is beginning to price OSW like a structurally improved compounder, not a cyclical services name. The second-order read-through is mixed for cruise operators and cruise suppliers. Stronger Caribbean mix and wellness attach rates argue for better onboard revenue per passenger, which should aid cruise lines with more premium itineraries and higher-income customer bases; however, it also intensifies competition for high-spend travelers and may force weaker operators to discount cabins to preserve occupancy. If oil or geopolitical shocks hit, OSW is exposed twice: lower discretionary spend and potentially less favorable cruise routing, which could pressure both volume and mix within one to two quarters. The key contrarian point is that the estimate revisions are not a clean earnings upgrade; EBITDA rose while EPS was cut, which suggests investors may be extrapolating valuation faster than per-share economics are actually improving. That leaves room for multiple disappointment if labor, ship-board costs, or share count dilution prevent operating leverage from flowing through. Near term, the stock can keep grinding higher on sentiment, but the setup is vulnerable if the next quarterly print shows any slowdown in premium spend or if management guidance turns more cautious on 2H demand. For positioning, the trade is better expressed as a relative-long than a naked chase: OSW can outperform cruise exposure if premium wellness spend stays resilient, but absolute upside from current levels is increasingly valuation-dependent. I would respect the momentum, but only with a tighter time horizon and a defined exit if the growth/margin mix fails to improve over the next 1-2 quarters.